These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 9613140)

  • 1. [Quantitative analysis of telomerase activity in exfoliated urothelial cells for the diagnosis of bladder carcinoma].
    Yokota K; Kanayama H; Kagawa S; Abe-Hashimoto J; Hirose M; Yoshimura T
    Nihon Rinsho; 1998 May; 56(5):1292-8. PubMed ID: 9613140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer.
    Dalbagni G; Han W; Zhang ZF; Cordon-Cardo C; Saigo P; Fair WR; Herr H; Kim N; Moore MA
    Clin Cancer Res; 1997 Sep; 3(9):1593-8. PubMed ID: 9815848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of telomerase activity in bladder carcinoma and exfoliated cells collected in urine and bladder washings, using a quantitative assay.
    Gelmini S; Crisci A; Salvadori B; Pazzagli M; Selli C; Orlando C
    Clin Cancer Res; 2000 Jul; 6(7):2771-6. PubMed ID: 10914723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Telomerase activity and determination of cancer in urological neoplasias using exfoliated urinary cells: in situ TRAP assay and its application].
    Ohyashiki K; Yahata N; Iwama H; Aizawa T; Miki M
    Nihon Rinsho; 1998 May; 56(5):1299-303. PubMed ID: 9613141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semi-quantitative analysis of telomerase activity in exfoliated human urothelial cells and bladder transitional cell carcinoma.
    Yokota K; Kanda K; Inoue Y; Kanayama H; Kagawa S
    Br J Urol; 1998 Nov; 82(5):727-32. PubMed ID: 9839590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of bladder cancer using telomerase activity in voided urine.
    Cheng CW; Chueh SC; Chern HD
    J Formos Med Assoc; 2000 Dec; 99(12):920-5. PubMed ID: 11155745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of screening methods in the detection of bladder cancer.
    Ramakumar S; Bhuiyan J; Besse JA; Roberts SG; Wollan PC; Blute ML; O'Kane DJ
    J Urol; 1999 Feb; 161(2):388-94. PubMed ID: 9915409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of human telomerase RNA and telomerase activity in urine for diagnosis of bladder cancer.
    Müller M; Krause H; Heicappell R; Tischendorf J; Shay JW; Miller K
    Clin Cancer Res; 1998 Aug; 4(8):1949-54. PubMed ID: 9717824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Numerical aberrations of chromosomes 11 and 17 detected by fish--fluorescence in situ hybridization combined with cytology in exfoliated cells from voided urine in patients with urothelial carcinoma of the bladder].
    Asali MG; Kaneti J; Manor E
    Harefuah; 2007 Dec; 146(12):914-9, 1000. PubMed ID: 18254439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The simultaneous use of telomerase, cytokeratin 20 and CD4 for bladder cancer detection in urine.
    Siracusano S; Niccolini B; Knez R; Tiberio A; Benedetti E; Bonin S; Ciciliato S; Pappagallo GL; Belgrano E; Stanta G
    Eur Urol; 2005 Mar; 47(3):327-33. PubMed ID: 15716196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of telomerase in urine by 3 methods: evaluation of diagnostic accuracy for bladder cancer.
    Eissa S; Swellam M; Ali-Labib R; Mansour A; El-Malt O; Tash FM
    J Urol; 2007 Sep; 178(3 Pt 1):1068-72. PubMed ID: 17644139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.
    Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E
    Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase activity in urine in diagnosis and recurrence surveillance of urothelial carcinoma.
    Li Z; Kong C; Wang P; Liu X; Liu T
    Chin Med J (Engl); 2002 Nov; 115(11):1650-2. PubMed ID: 12609080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of fluorescence in situ hybridization of urine exfoliative cells in diagnosis of urinary bladder neoplasms].
    Chen N; Gong J; Zeng H; Wei Q; Zhu YC; Chen M; Zhou Q
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Jan; 42(1):109-13. PubMed ID: 21355314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase: a potential marker of bladder transitional cell carcinoma in bladder washes.
    Lee DH; Yang SC; Hong SJ; Chung BH; Kim IY
    Clin Cancer Res; 1998 Mar; 4(3):535-8. PubMed ID: 9533519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective evaluation of genetic abnormalities and telomerase expression in exfoliated urinary cells for bladder cancer detection.
    Neves M; Ciofu C; Larousserie F; Fleury J; Sibony M; Flahault A; Soubrier F; Gattegno B
    J Urol; 2002 Mar; 167(3):1276-81. PubMed ID: 11832713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible role of telomerase and sFas in pathogenesis of various bladder lesions associated with schistosomiasis.
    Shaker OG; Hammam O; Salehd A; el-Leithy T; Wishahi M
    Clin Biochem; 2009 Jun; 42(9):864-72. PubMed ID: 19272297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Over expression of CD44V8-10 in urinary exfoliated cells as an independent prognostic predictor in patients with urothelial cancer.
    Miyake H; Eto H; Arakawa S; Kamidono S; Hara I
    J Urol; 2002 Mar; 167(3):1282-7. PubMed ID: 11832714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of BTA stat, hemoglobin dipstick, telomerase and Vysis UroVysion assays for the detection of urothelial carcinoma in urine.
    Halling KC; King W; Sokolova IA; Karnes RJ; Meyer RG; Powell EL; Sebo TJ; Cheville JC; Clayton AC; Krajnik KL; Ebert TA; Nelson RE; Burkhardt HM; Ramakumar S; Stewart CS; Pankratz VS; Lieber MM; Blute ML; Zincke H; Seelig SA; Jenkins RB; O'Kane DJ
    J Urol; 2002 May; 167(5):2001-6. PubMed ID: 11956427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
    Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.